BMRN
BioMarin Pharmaceutical Inc.
Set alert
58.51 USD +1.02 +1.77%
57.86 Day range 59.37
49.67 52-week range 70.24
- YTD
- -1.55%
- 1 year
- +12.71%
- Open
- 58.39
- Prev close
- 57.49
- Mkt cap
- 11.33B
- Vol
- 2.27M
- Avg vol
- 2.25M
- EPS
- 0.37
- P/E
- 158.13
- Div yield
- 0.00%
More statistics
- Low
- 57.86
- High
- 59.37
- Forward P/E
- 9.12
- Beta
- 0.21
- Short ratio
- 5.25
- Inst. own
- 103.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 60.80
- 200-d avg
- 58.42
- 1y target
- 91.56
1Y chart
Closing price and volume
Compare BMRN
Chart and line up BMRN against other symbols or a saved comparison set.
- BMRN BioMarin Pharmaceutical Inc.
58.51
+1.02 +1.77%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | BMRN | SPY | QQQ |
|---|---|---|---|
| Last price | 58.51 | 755.72 | 690.49 |
| Change | +1.02 | -13.64 | -24.85 |
| Change % | +1.77% | -1.77% | -3.47% |
| Open | 58.39 | 761.38 | 697.13 |
| Day high | 59.37 | 761.46 | 698.63 |
| Day low | 57.86 | 750.36 | 683.45 |
| Previous close | 57.49 | 769.36 | 715.34 |
| Volume | 2.27M | 77.70M | 85.24M |
| Average volume | 2.25M | 41.22M | 34.57M |
| Market cap | 11.33B | 812.08B | 483.28B |
| P/E ratio | 158.14 | 23.99 | 26.44 |
| Earnings per share | 0.37 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 70.24 | 779.09 | 759.66 |
| 52-week low | 49.67 | 631.97 | 558.28 |
| 1-week return | +4.58% | -0.559233% | -1.97% |
| 1-month return | -2.48% | -0.906075% | -6.66% |
| 3-month return | -3.42% | +1.89% | +1.02% |
| 6-month return | +8.53% | +5.16% | +3.41% |
| Year-to-date return | -1.55% | +10.82% | +12.40% |
| 1-year return | +12.71% | +11.16% | +10.29% |
| 2-year return | -11.20% | +32.90% | +42.71% |
| 50-day moving average | 60.80 | 767.63 | 725.41 |
| 200-day moving average | 58.42 | 728.53 | 679.17 |
| Target price | 91.56 | — | — |
| Beta | 0.215 | 0.00 | 0.00 |
| Short ratio | 5.25 | — | — |
| Institutional ownership | 103.27% | — | — |